Skip to main content
Year archive

ARGENT BIOPHARMA LIMITED — 2023 filings

All 125 regulatory filings released by ARGENT BIOPHARMA LIMITED (RGT) in 2023, sourced directly from the official regulator.

125 Filings
2023 Period
2023 filings (125)
Filing Released Lang
Company Update & Capital Raising 3 pages 269.5KB
Capital/Financing Update
2023-12-21 English
Proposed issue of securities - MXC 6 pages 31.3KB
Capital/Financing Update
2023-12-21 English
Pause in trading 1 page 119.3KB
Regulatory Filings
2023-12-20 English
Retraction of Statement 1 page 209.6KB
Regulatory Filings
2023-12-20 English
ArtemiC Receives FDA Approval in Saudi Arabia 2 pages 254.7KB
Regulatory Filings
2023-12-18 English
MGC Pharma Non-Deal Roadshow Presentation December 2023 17 pages 2.8MB
Investor Presentation
2023-12-17 English
Corporate Update - Board and UK Adviser Changes 2 pages 220.8KB
Board/Management Information
2023-11-30 English
Final Director's Interest Notice x 2 4 pages 436.0KB
Director's Dealing
2023-11-30 English
Initial Director's Interest Notice 1 page 205.4KB
Director's Dealing
2023-11-30 English
Notification regarding unquoted securities - MXC 7 pages 32.3KB
Share Issue/Capital Change
2023-11-30 English
Application for quotation of securities - MXC 7 pages 32.4KB
Capital/Financing Update
2023-11-30 English
s708A(5)(e) Cleansing Notice 2 pages 232.1KB
Capital/Financing Update
2023-11-30 English
Results of Meeting 3 pages 506.4KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-29 English
Change in substantial holding 3 pages 27.6KB
Major Shareholding Notification
2023-11-08 English
Capital Consolidation and US$7.9m Placement Completed 2 pages 231.3KB
Capital/Financing Update
2023-11-07 English
Application for quotation of securities - MXC 6 pages 27.8KB
Capital/Financing Update
2023-11-06 English
Notification regarding unquoted securities - MXC 7 pages 31.8KB
Share Issue/Capital Change
2023-11-06 English
s708A(5)(e) Cleansing Notice 2 pages 231.7KB
Regulatory Filings
2023-11-06 English
MGC Secures US$7.9 Million in Firm Commitments 3 pages 290.5KB
Capital/Financing Update
2023-10-31 English
Proposed issue of securities - MXC 7 pages 32.4KB
Capital/Financing Update
2023-10-31 English
Notice of Annual General Meeting/Proxy Form 38 pages 809.9KB
AGM Information
2023-10-30 English
Trading Halt 2 pages 605.1KB
Capital/Financing Update
2023-10-29 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 649.6KB
Interim / Quarterly Report
2023-10-29 English
Results of Meeting 2 pages 500.6KB
Declaration of Voting Results & Voting Rights Announcements
2023-10-24 English
Consolidation/Split - MXC 8 pages 35.4KB
Share Issue/Capital Change
2023-10-23 English
Annual General Meeting Update 1 page 211.1KB
AGM Information
2023-10-08 English
Annual Report to shareholders 65 pages 3.7MB
Regulatory Filings
2023-09-28 English
Appendix 4G and Corporate Governance Statement 27 pages 721.9KB
Regulatory Filings
2023-09-28 English
Notice of General Meeting/Proxy Form 19 pages 861.0KB
Proxy Solicitation & Information Statement
2023-09-25 English
Managing Director's Letter to Shareholders 3 pages 264.7KB
Management Reports
2023-09-25 English
Change in substantial holding 4 pages 99.9KB
Major Shareholding Notification
2023-09-07 English
Notification regarding unquoted securities - MXC 7 pages 31.8KB
Share Issue/Capital Change
2023-09-05 English
Application for quotation of securities - MXC 6 pages 28.2KB
Share Issue/Capital Change
2023-09-05 English
Application for quotation of securities - MXC 6 pages 28.6KB
Capital/Financing Update
2023-09-05 English
s708A(5)(e) Cleansing Notice 2 pages 230.9KB
Capital/Financing Update
2023-09-05 English
Results of Meeting 2 pages 271.1KB
Declaration of Voting Results & Voting Rights Announcements
2023-09-04 English
Application for quotation of securities - MXC 6 pages 27.9KB
Capital/Financing Update
2023-08-31 English
Notification of cessation of securities - MXC 4 pages 23.9KB
Share Issue/Capital Change
2023-08-31 English
Change of Share Registry Address 2 pages 215.2KB
Regulatory Filings
2023-08-31 English
Preliminary Final Report 15 pages 905.6KB
Annual Report
2023-08-30 English
Share Purchase Plan Closed 2 pages 239.9KB
Capital/Financing Update
2023-08-29 English
Extension of Share Purchase Plan Closing Date 2 pages 226.8KB
Capital/Financing Update
2023-08-14 English
Update - Proposed issue of securities - MXC 8 pages 36.1KB
Capital/Financing Update
2023-08-14 English
Pre-clinical Trial Results on CimetrA 3 pages 303.5KB
Regulatory Filings
2023-08-13 English
Notice of General Meeting/Proxy Form 20 pages 896.0KB
Proxy Solicitation & Information Statement
2023-08-03 English
Prospectus and Share Purchase Plan Documents 48 pages 837.6KB
Capital/Financing Update
2023-08-02 English
Company Update 2 pages 226.1KB
Capital/Financing Update
2023-08-01 English
MGC Pharma Launches Share Purchase Plan 2 pages 232.0KB
Capital/Financing Update
2023-07-31 English
Proposed issue of securities - MXC 8 pages 36.5KB
Capital/Financing Update
2023-07-31 English
MGC receives permission for first import of Psilocybin 2 pages 272.5KB
Regulatory Filings
2023-07-30 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 812.6KB
Interim / Quarterly Report
2023-07-27 English
Resignation of Joint Company Secretary 2 pages 220.5KB
Board/Management Information
2023-07-27 English
Clarification Announcement 2 pages 283.9KB
Capital/Financing Update
2023-07-20 English
Change in substantial holding 8 pages 237.5KB
Major Shareholding Notification
2023-07-18 English
Commitments Received for GBP 0.7m 4 pages 852.5KB
Capital/Financing Update
2023-07-13 English
Proposed issue of securities - MXC 7 pages 32.9KB
Capital/Financing Update
2023-07-13 English
Proposed issue of securities - MXC 5 pages 27.6KB
Capital/Financing Update
2023-07-13 English
Update - Proposed issue of securities - MXC 7 pages 32.7KB
Capital/Financing Update
2023-07-13 English
Application for quotation of securities - MXC 6 pages 29.8KB
Capital/Financing Update
2023-07-13 English
Notification regarding unquoted securities - MXC 7 pages 32.6KB
Capital/Financing Update
2023-07-13 English
s708A(5)(e) Cleansing Notice 2 pages 344.4KB
Share Issue/Capital Change
2023-07-13 English
Clarification Announcement 2 pages 239.6KB
Regulatory Filings
2023-07-11 English
AMC Places Second Order of ArtemiC for US$1M 2 pages 266.7KB
Regulatory Filings
2023-07-06 English
MGC Welcomes Reclassification of Psychedelic Compounds 2 pages 215.5KB
Regulatory Filings
2023-07-02 English
Company Update 2 pages 227.2KB
Board/Management Information
2023-06-29 English
Details of Company Address 2 pages 244.7KB
Regulatory Filings
2023-06-29 English
Results of Meeting 2 pages 494.1KB
Declaration of Voting Results & Voting Rights Announcements
2023-06-28 English
Application for quotation of securities - MXC 6 pages 28.1KB
Share Issue/Capital Change
2023-06-20 English
s708A(5)(e) Cleansing Notice 2 pages 250.4KB
Share Issue/Capital Change
2023-06-20 English
Appointment of Non-Executive Director 2 pages 232.3KB
Board/Management Information
2023-05-31 English
Initial Director's Interest Notice 1 page 214.9KB
Director's Dealing
2023-05-31 English
Final Director's Interest Notice x 2 4 pages 459.9KB
Director's Dealing
2023-05-31 English
First CannEpil Delivered to UK Patients 3 pages 309.6KB
Regulatory Filings
2023-05-30 English
Distribution of General Meeting Documents - Notice of Access 2 pages 267.8KB
Proxy Solicitation & Information Statement
2023-05-29 English
Notice of General Meeting/Proxy Form 27 pages 541.5KB
Proxy Solicitation & Information Statement
2023-05-29 English
Corporate Update - Board and UK Adviser Changes 2 pages 237.6KB
Board/Management Information
2023-05-29 English
Notification of cessation of securities - MXC 4 pages 24.5KB
Share Issue/Capital Change
2023-05-04 English
Notification regarding unquoted securities - MXC 5 pages 26.3KB
Capital/Financing Update
2023-05-04 English
Application for quotation of securities - MXC 7 pages 30.7KB
Capital/Financing Update
2023-05-04 English
Application for quotation of securities - MXC 6 pages 28.6KB
Capital/Financing Update
2023-05-04 English
s708A(5)(e) Cleansing Notice 2 pages 272.7KB
Share Issue/Capital Change
2023-05-04 English
Change in Director's Interests x 5 13 pages 834.9KB
Director's Dealing
2023-05-04 English
Malta Production Facility Receives EU-GMP Approval 2 pages 276.7KB
Regulatory Filings
2023-05-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 595.3KB
Interim / Quarterly Report
2023-04-27 English
Application for quotation of securities - MXC 6 pages 27.8KB
Capital/Financing Update
2023-04-19 English
Notification regarding unquoted securities - MXC 7 pages 31.2KB
Capital/Financing Update
2023-04-19 English
s708A(5)(e) Cleansing Notice 2 pages 244.2KB
Share Issue/Capital Change
2023-04-19 English
Becoming a substantial holder 3 pages 160.8KB
Major Shareholding Notification
2023-04-17 English
Application for quotation of securities - MXC 6 pages 27.9KB
Capital/Financing Update
2023-04-13 English
s708A(5)(e) Cleansing Notice 2 pages 250.9KB
Share Issue/Capital Change
2023-04-13 English
Fundraise closed raising up to a total of GBP 2.09m 2 pages 312.8KB
Capital/Financing Update
2023-04-12 English
Proposed issue of securities - MXC 6 pages 31.3KB
Capital/Financing Update
2023-04-12 English
Proposed issue of securities - MXC 6 pages 31.0KB
Capital/Financing Update
2023-04-12 English
Trading Halt 2 pages 599.3KB
Capital/Financing Update
2023-04-10 English
Funding Commitments Received for GBP 1.8m 6 pages 471.0KB
Capital/Financing Update
2023-04-10 English
MGC Pharma Investor Presentation April 2023 15 pages 6.4MB
Investor Presentation
2023-04-10 English
CannEpil now available by Named Patient Request in UK 3 pages 273.7KB
Regulatory Filings
2023-04-10 English
Notification of cessation of securities - MXC 4 pages 24.9KB
Share Issue/Capital Change
2023-04-02 English
MGC Receive Permission for Psilocybin Research & Development 2 pages 236.3KB
Regulatory Filings
2023-04-02 English
Results of Meeting 2 pages 504.6KB
Declaration of Voting Results & Voting Rights Announcements
2023-03-29 English
ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order 3 pages 253.0KB
Capital/Financing Update
2023-03-20 English
First patient enrolled in MGC ZAM App CannEpil Trial 2 pages 213.1KB
Regulatory Filings
2023-03-14 English
Notification regarding unquoted securities - MXC 5 pages 26.5KB
Capital/Financing Update
2023-03-08 English
Proposed issue of securities - MXC 5 pages 27.4KB
Capital/Financing Update
2023-03-07 English
s708A(12C)(e) Cleansing Notice 14 pages 295.7KB
Capital/Financing Update
2023-03-07 English
Provision of US$500,000 Funding 2 pages 219.0KB
Capital/Financing Update
2023-03-07 English
Completion of CimetrA Mechanism of Action study 4 pages 323.6KB
Regulatory Filings
2023-03-06 English
Appointment of UK Lead Broker Change of Company Secretary 1
Board/Management Information
2023-02-28 English
Distribution of General Meeting Documents - Notice of Access 2 pages 328.2KB
Proxy Solicitation & Information Statement
2023-02-27 English
Notice of General Meeting/Proxy Form 38 pages 422.1KB
Proxy Solicitation & Information Statement
2023-02-27 English
Half Year Accounts 25 pages 784.3KB
Interim / Quarterly Report
2023-02-27 English
Application for quotation of securities - MXC 6 pages 28.1KB
Share Issue/Capital Change
2023-02-27 English
s708A(5)(e) Cleansing Notice 2 pages 285.3KB
Share Issue/Capital Change
2023-02-27 English
Investor Presentation 13 pages 4.3MB
Investor Presentation
2023-02-09 English
Notification regarding unquoted securities - MXC 6 pages 28.3KB
Share Issue/Capital Change
2023-02-05 English
Provision of US$600,000 Funding and change of CFO 2 pages 209.5KB
Capital/Financing Update
2023-02-02 English
Refinancing and Extension to Convertible Security Agreements 3 pages 223.7KB
Capital/Financing Update
2023-02-01 English
Proposed issue of securities - MXC 5 pages 27.4KB
Capital/Financing Update
2023-02-01 English
Proposed issue of securities - MXC 5 pages 28.9KB
Capital/Financing Update
2023-02-01 English
s708A(12C)(e) Cleansing Notice 13 pages 380.7KB
Capital/Financing Update
2023-02-01 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 1.6MB
Interim / Quarterly Report
2023-01-29 English
Change of External Financial Auditor 2 pages 222.6KB
Board/Management Information
2023-01-10 English
Results of CimetrA bioanalytics pre-clinal trial 7 pages 359.4KB
Regulatory Filings
2023-01-09 English
Internal Costs Review Completed and Board Change 2 pages 227.1KB
Board/Management Information
2023-01-02 English
Final Director's Interest Notice 2 pages 284.2KB
Director's Dealing
2023-01-02 English